P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL

ABSTRACT:

SUBMITTER: Rodriguez-Otero P 

PROVIDER: S-EPMC9011718 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature